Don­ald Trump sends a vague­ly word­ed love let­ter to bio­phar­ma as stock ral­ly con­tin­ues

The big bio­phar­ma stock ral­ly con­tin­ued to per­co­late through Day Two of the af­ter­math of Don­ald Trump’s elec­tion. And that wasn’t hurt in the least by the pres­i­dent-elect’s promise to re­form the FDA once he gets in­to of­fice, 70 days from now.

Trump’s post-elec­tion mis­sion state­ment for his ad­min­is­tra­tion on health­care — post­ed at greata­gain.gov — starts with the re­peal of Oba­macare and goes on to make a cou­ple of vague promis­es that may well spell new ben­e­fits for the in­dus­try. In­clud­ed in that ros­ter:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER